Overall Health Status of Patients with Mild-to-Moderate Cubital Tunnel Syndrome: A Case-Control Study

轻中度肘管综合征患者的总体健康状况:一项病例对照研究

阅读:1

Abstract

Objectives: This cross-sectional case-control study, conducted at the Department of Physiotherapy, Academy of Physical Education, in Katowice, between July 2022 and April 2023, aimed to assess the overall health status (OHS) of patients with mild-to-moderate cubital tunnel syndrome (CuTS) compared with a healthy control population. Methods: The SF-36 questionnaire was used to evaluate the following domains: physical functioning (PF), role limitations due to physical health problems (RP), bodily pain (BP), general health (GH), vitality (VT), social functioning (SF), role limitations due to emotional problems (RE), and mental health (MH). Results: A total of 152 participants were enrolled in the study. The CuTS and control groups consisted of 82 and 70 individuals, respectively. The CuTS group had significantly lower scores in most domains when compared with the control group; however, no significant difference was observed in the BP domain. Notably, the VT domain showed a statistically significant difference in favor of the CuTS group, indicating slightly higher perceived vitality despite functional limitations. Conclusions: Mild and moderate forms of CuTS are associated with significant deterioration in general health, encompassing both physical and psychological components, as assessed by the SF-36 questionnaire; however, no significant difference was observed in the BP domain, suggesting that the burden of CuTS may manifest more strongly in functional, psychosocial, and mental health aspects rather than in generalized pain perception. These findings highlight the importance of a comprehensive evaluation and management strategy that addresses both physical and psychosocial dimensions of patient care.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。